Sodium–Glucose Cotransporter-2 Inhibitors and the Risk for Severe Urinary Tract InfectionsChintan V. Dave, Elisabetta Patorno, Angela Tong et al.|Annals of Internal Medicine|2019Cited by 215
Risk of Cardiovascular Outcomes in Patients With Type 2 Diabetes After Addition of SGLT2 Inhibitors Versus Sulfonylureas to Baseline GLP-1RA TherapyChintan V. Dave, Elisabetta Patorno, Seoyoung C. Kim et al.|Circulation|2020Cited by 93